Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
npj Primary Care Respiratory Medicine, Published online: 25 May 2021; doi:10.1038/s41533-021-00241-zSingle-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
Source: npj Primary Care Respiratory Medicine - Category: Primary Care Authors: Sandeep Bansal Martin Anderson Antonio Anzueto Nicola Brown Chris Compton Thomas C. Corbridge David Erb Catherine Harvey Morrys C. Kaisermann Mitchell Kaye David A. Lipson Neil Martin Chang-Qing Zhu Alberto Papi Source Type: research
More News: Chronic Obstructive Pulmonary | Flonase | Primary Care | Respiratory Medicine | Spiriva | Tiotropium